The Global Cancer Supportive Care Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
Scope of the Report:
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
The high investment in the oncology segment and pharmaceutical industry in US and Canada, and the presence of several large vendors operating in US contribute to the growth of the palliative cancer care market in the Americas. Additionally, constant R&D activities in the oncology sector, strong economic condition, and huge investments in the healthcare segment further contribute to the market growth.
The worldwide market for Cancer Supportive Care is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.
This report focuses on the Cancer Supportive Care in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Amgen
- Helsinn Healthcare
- Johnson &Johnson
- Merck
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Novartis
- TESARO
- Teva Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Nonsteroidal Erythropoietin Stimulating Agents
- Opioid Analgesics
- Anti-Imflammatory Drugs
- Anti-Infective Drugs
- Bisphosphonates
- Anti-Emetics Drugs
- Monoclonal Antibodies
- Granulocyte Colony Stimulating Factor
Market Segment by Applications, can be divided into
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Liver Cancer
- Bladder Cancer
- Leukemia
- Ovarian Cancer
- Melanoma
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Supportive Care product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Supportive Care, with price, sales, revenue and global market share of Cancer Supportive Care in 2017 and 2018.
Chapter 3, the Cancer Supportive Care competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Supportive Care breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cancer Supportive Care market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cancer Supportive Care sales channel, distributors, customers, research findings and conclusion, appendix and data source.